If you used the birth control injection Depo-Provera and were later diagnosed with a meningioma (a tumor on the tissue surrounding the brain or spinal cord), you may qualify for compensation.
Every case is different — the fastest way to know where you stand is a free, no-obligation review.
Lawsuits allege that long-term use of Depo-Provera is linked to an increased risk of meningioma, and that patients weren't adequately warned of this risk.
Generally, extended use (a year or more) followed by a meningioma diagnosis. A free review is the fastest way to check your specific situation.
No — checking your eligibility through Atumio is free, with no obligation to move forward.
Filing deadlines vary by state and case specifics. Check your eligibility as soon as possible so a reviewing attorney can advise you on timing.
Your answers are reviewed against current case criteria. If you appear to qualify, someone from Atumio's vetted legal network may contact you — there's never an obligation to proceed.
Judge M. Casey Rodgers appointed Matt Garretson as allocation master and CPA Randall Sansom as fund administrator for Pfizer's Depo-Provera settlement, and federal plaintiffs must register by November 30, 2026, with first payments expected in early 2027.
Read more →In December 2025, the FDA approved new label language warning that Depo-Provera use is linked to meningioma brain tumors, reversing an earlier decision that had rejected Pfizer's own request for the warning in 2024.
Read more →In February 2025, the federal judicial panel consolidated Depo-Provera meningioma lawsuits into a new multidistrict litigation in Florida, and filings have grown from 27 cases to thousands within about a year.
Read more →Free and confidential. Takes about 2 minutes.
Thanks — we've received your information for your Depo-Provera case review. A member of Atumio's vetted legal network may reach out by phone or email soon. There's never any obligation to proceed.